Brian Dovey

Brian has been a partner of Domain since 1988, where he has led innovative investments in life sciences companies.

Since joining Domain, he has served on the board of directors of more than 35 private and public companies and has been chairman of six.

Prior to Domain, Brian was president of Rorer Group, now a part of Sanofi, where he was the primary architect of a strategy transforming the company from a diversified medical products company to a fully-integrated pharmaceutical company, doubling sales with a multi-fold increase in profits. Previous to that, Brian was president of Survival Technology, a startup that developed the Epipen and whose sales growth placed it in the top ten of the Inc 100.

Brian was former chairman and currently serves on the board of directors of both the Center for Venture Education (Kauffman Fellows Program) and the Wistar Institute, a leader in preclinical bio-medical research in the non-profit sector. He is a member of the Board of Overseers of Scripps Research, which is also a leader in biomedical research. He is also a member of the Board of Trustees of the La Jolla Playhouse.

Brian was past chairman of the National Venture Capital Association. He is a trustee emeritus of Germantown Academy and is a former trustee of the University of Pennsylvania School of Nursing and the Sanford Burnham Prebys Medical Discovery Institute. He is also a former board member of the industry associations representing the medical device industry as well as the association representing consumer pharmaceuticals. He received his B.A. in mathematics from Colgate University and his MBA from Harvard Business School.